Allogeneic natural killer (NK) cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic natural killer (NK) cell therapy, covering 2016-07-27 to 2016-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab [Phase 1]